Pathologic handling and reporting of prostate tissue specimens in patients receiving neoadjuvant hormonal therapy: Report of the pathology committee

David Grignon, D. G. Bostwick, F. Civantos, M. B. Garnick, P. Gaudin, J. R. Srigley, C. Sternberg, S. Howell, P. Albertsen, W. Fair

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Prior meetings of the International Conference on Neoadjuvant Hormonal Therapy in Prostate Cancer identified areas of concern in the pathologic analysis of post-treatment specimens. In response, a pathology subcommittee was formed to address the questions that had been raised. Recommendations are made here concerning pretreatment biopsy review and reporting, handling and reporting of radical prostatectomy specimens, Gleason scoring of treated cancer, grading of therapy effect, role of immunohistochemistry procedures, and the significance of high-grade prostatic intraepithelial neoplasia. Neoadjuvant trials with both surgery and radiation therapy were considered in drawing up these recommendations.

Original languageEnglish (US)
Pages (from-to)193-200
Number of pages8
JournalMolecular Urology
Volume3
Issue number3
StatePublished - 1999
Externally publishedYes

Fingerprint

Neoadjuvant Therapy
Prostate
Prostatic Intraepithelial Neoplasia
Pathology
Prostatectomy
Prostatic Neoplasms
Radiotherapy
Immunohistochemistry
Biopsy
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Pathologic handling and reporting of prostate tissue specimens in patients receiving neoadjuvant hormonal therapy : Report of the pathology committee. / Grignon, David; Bostwick, D. G.; Civantos, F.; Garnick, M. B.; Gaudin, P.; Srigley, J. R.; Sternberg, C.; Howell, S.; Albertsen, P.; Fair, W.

In: Molecular Urology, Vol. 3, No. 3, 1999, p. 193-200.

Research output: Contribution to journalArticle

Grignon, D, Bostwick, DG, Civantos, F, Garnick, MB, Gaudin, P, Srigley, JR, Sternberg, C, Howell, S, Albertsen, P & Fair, W 1999, 'Pathologic handling and reporting of prostate tissue specimens in patients receiving neoadjuvant hormonal therapy: Report of the pathology committee', Molecular Urology, vol. 3, no. 3, pp. 193-200.
Grignon, David ; Bostwick, D. G. ; Civantos, F. ; Garnick, M. B. ; Gaudin, P. ; Srigley, J. R. ; Sternberg, C. ; Howell, S. ; Albertsen, P. ; Fair, W. / Pathologic handling and reporting of prostate tissue specimens in patients receiving neoadjuvant hormonal therapy : Report of the pathology committee. In: Molecular Urology. 1999 ; Vol. 3, No. 3. pp. 193-200.
@article{8316a23a03e047b18d6d91108ae596b4,
title = "Pathologic handling and reporting of prostate tissue specimens in patients receiving neoadjuvant hormonal therapy: Report of the pathology committee",
abstract = "Prior meetings of the International Conference on Neoadjuvant Hormonal Therapy in Prostate Cancer identified areas of concern in the pathologic analysis of post-treatment specimens. In response, a pathology subcommittee was formed to address the questions that had been raised. Recommendations are made here concerning pretreatment biopsy review and reporting, handling and reporting of radical prostatectomy specimens, Gleason scoring of treated cancer, grading of therapy effect, role of immunohistochemistry procedures, and the significance of high-grade prostatic intraepithelial neoplasia. Neoadjuvant trials with both surgery and radiation therapy were considered in drawing up these recommendations.",
author = "David Grignon and Bostwick, {D. G.} and F. Civantos and Garnick, {M. B.} and P. Gaudin and Srigley, {J. R.} and C. Sternberg and S. Howell and P. Albertsen and W. Fair",
year = "1999",
language = "English (US)",
volume = "3",
pages = "193--200",
journal = "Molecular Urology",
issn = "1091-5362",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Pathologic handling and reporting of prostate tissue specimens in patients receiving neoadjuvant hormonal therapy

T2 - Report of the pathology committee

AU - Grignon, David

AU - Bostwick, D. G.

AU - Civantos, F.

AU - Garnick, M. B.

AU - Gaudin, P.

AU - Srigley, J. R.

AU - Sternberg, C.

AU - Howell, S.

AU - Albertsen, P.

AU - Fair, W.

PY - 1999

Y1 - 1999

N2 - Prior meetings of the International Conference on Neoadjuvant Hormonal Therapy in Prostate Cancer identified areas of concern in the pathologic analysis of post-treatment specimens. In response, a pathology subcommittee was formed to address the questions that had been raised. Recommendations are made here concerning pretreatment biopsy review and reporting, handling and reporting of radical prostatectomy specimens, Gleason scoring of treated cancer, grading of therapy effect, role of immunohistochemistry procedures, and the significance of high-grade prostatic intraepithelial neoplasia. Neoadjuvant trials with both surgery and radiation therapy were considered in drawing up these recommendations.

AB - Prior meetings of the International Conference on Neoadjuvant Hormonal Therapy in Prostate Cancer identified areas of concern in the pathologic analysis of post-treatment specimens. In response, a pathology subcommittee was formed to address the questions that had been raised. Recommendations are made here concerning pretreatment biopsy review and reporting, handling and reporting of radical prostatectomy specimens, Gleason scoring of treated cancer, grading of therapy effect, role of immunohistochemistry procedures, and the significance of high-grade prostatic intraepithelial neoplasia. Neoadjuvant trials with both surgery and radiation therapy were considered in drawing up these recommendations.

UR - http://www.scopus.com/inward/record.url?scp=0032759993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032759993&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032759993

VL - 3

SP - 193

EP - 200

JO - Molecular Urology

JF - Molecular Urology

SN - 1091-5362

IS - 3

ER -